Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/09/11/2741034/0/en/Hillstream-Enters-into-an-Exclusive-Option-Agreement-to-Acquire-a-Clinical-Stage-Asset-for-Chronic-Pruritis.html
https://www.globenewswire.com//news-release/2023/09/08/2740295/0/en/Hillstream-BioPharma-to-Present-at-H-C-Wainwright-25th-Annual-Global-Investment-Conference-September-11-13.html
https://www.globenewswire.com/news-release/2023/08/09/2721669/0/en/Hillstream-BioPharma-to-Present-at-the-Sidoti-Micro-Cap-Virtual-Conference-on-August-16-17-2023.html
https://www.globenewswire.com/news-release/2023/07/20/2708133/0/en/Hillstream-Advances-Next-Gen-Multispecific-Antibodies-for-Solid-Tumors-with-Lead-HER2-HER3-Program-HSB-3215.html
https://www.globenewswire.com/news-release/2023/07/10/2701788/0/en/Hillstream-BioPharma-Announces-Strategic-Reprioritization-of-Pipeline-to-Targeting-HER2-HER3-Solid-Tumors-via-Bispecific-and-ADC-Antibodies-and-Biologics.html
https://www.globenewswire.com/news-release/2023/07/06/2700331/0/en/Hillstream-BioPharma-Licenses-Technology-to-Develop-Proprietary-HER2-and-HER3-Antibody-Drug-Conjugates-against-Drug-Resistant-Breast-Lung-Gastric-and-Ovarian-Cancers.html
https://www.globenewswire.com/news-release/2023/05/15/2668814/0/en/Hillstream-BioPharma-Strengthens-its-Board-of-Directors-with-Appointment-of-Kelly-Anderson.html
https://www.globenewswire.com/news-release/2023/05/02/2659764/0/en/Hillstream-BioPharma-Announces-Closing-of-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com/news-release/2023/05/02/2659204/0/en/Hillstream-BioPharma-to-Present-at-Upcoming-May-2023-Investor-and-Industry-Conferences.html
https://www.globenewswire.com/news-release/2023/04/28/2657068/0/en/Hillstream-BioPharma-Announces-Pricing-of-Public-Offering.html